Related Experiment Video
Updated: May 5, 2026

Creation of Murine Experimental Abdominal Aortic Aneurysms with Elastase
Published on: July 23, 2009
Stanford Type B Aortic Dissection in a Patient With Osteogenesis Imperfecta: A Case Report
1Department of Vascular Surgery, Royal Melbourne Hospital, Parkville, VIC, Australia.
Insights
Osteogenesis imperfecta patients rarely experience aortic dissection. This case highlights successful conservative management of Stanford Type B aortic dissection with beta-blockers and close surveillance, emphasizing individualized care for connective tissue disorders.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Connective Tissue Diseases
Background:
- Osteogenesis imperfecta (OI) is a rare genetic disorder affecting type-1 collagen production.
- Cardiovascular issues like aortic regurgitation are common in OI, but aortic dissection is exceptionally rare.
- Managing vascular complications in OI is challenging due to tissue fragility.
Purpose of the Study:
- To report a rare case of Stanford Type B aortic dissection in a patient with osteogenesis imperfecta.
- To discuss the management and outcomes of this rare presentation.
- To emphasize the need for individualized treatment strategies in OI patients with vascular pathology.
Main Methods:
- A case report of a 69-year-old female with genetically confirmed osteogenesis imperfecta.
- Diagnosis of acute, uncomplicated Stanford Type B aortic dissection via imaging.
- Management with beta-blocker therapy and close imaging surveillance.
Main Results:
- The patient's aortic dissection remained stable under medical management.
- She remained asymptomatic at 6-month follow-up.
- A reactive pleural effusion resolved without intervention.
Conclusions:
- Conservative management with beta-blockers can be effective for Type B aortic dissection in OI patients.
- Individualized management and intensive surveillance are crucial for OI patients with vascular complications.
- Awareness of connective tissue fragility is vital for surgical and long-term care planning.
Abstract:
Osteogenesis imperfecta is a group of rare, genetically inherited, autosomal dominant connective tissue disorders affecting the production of type-1 collagen. The most common cardiovascular manifestations of the pathology include aortic regurgitation and aortic root disease. Other manifestations remain particularly rare, with only 2 previously reported cases of type B aortic dissection in patients with osteogenesis imperfecta described in the literature. The management of vascular pathology in connective tissue disease remains a significant clinical challenge due to the intrinsic fragility of connective tissues and tendencies to bleed with open surgical repair. This is a case of a 69-year-old with a genetically confirmed diagnosis of osteogenesis imperfecta presenting with epigastric pain radiating to the back. She had vascular risk factors of hypertension and hypercholesterolaemia. Imaging revealed an acute, uncomplicated Stanford Type B aortic dissection, which was managed with intravenous and then oral beta-blocker therapy. Close imaging surveillance demonstrated stability in the extent of the dissection, and she remains asymptomatic at 6 months of follow-up. Notably, her inpatient stay was complicated by a reactive pleural effusion, which resolved without intervention. Given the rarity of aortic dissection in patients with osteogenesis imperfecta and the lack of clinical evidence to guide decision-making, this case report emphasizes the importance of an individualized approach to management in the acute phase with intensive outpatient surveillance. Awareness of the risks posed by connective tissue fragility in this patient population is essential in guiding both emergency and elective surgical management and long-term care planning.
Related Concept Videos
Aneurysm I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies

